The Leukemia & Lymphoma Society (SCOR grant)
Title: Targeting Unmet Needs For B-cell Lymphomas
Principal Investigator: Ethel Cesarman, MD PhD (Project 2 Lead)
Period of Support: 10/01/2022-09/30/2027
Total Direct Costs: $750,000 (Project 2)
National Institutes of Health (U01 grant subaward)
Title: Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
Principal Investigator: Ethel Cesarman, MD PhD
Period of Support: 06/10/2022-05/31/2027
Total Direct Costs: $361,050
National Institutes of Health (U01 grant)
Title: B cell determinants of EBV latency
Principal Investigator: Ethel Cesarman, MD PhD
Period of Support: 09/09/2022-08/31/2027
Total Direct Costs: $3,158,148
National Institutes of Health (T32 grant)
Title: Cancer Research Manpower
Principal Investigator: Ethel Cesarman, MD PhD; Co-PI: Matthew Greenblatt, MD PhD
Period of Support: 09/01/2022-08/31/2027
Total Direct Costs: $1,474,686
National Institutes of Health (K99 grant)
Title: A multi-stem cell basis for craniosynostosis
Principal Investigator: Shawon Debnath, PhD
Period of Support: 07/01/2022-06/30/2024
Total Direct Costs: $250,000
United States Department of Defense
Title: The skeletal stem cell basis for skeletal fragility
Principal Investigator: Shawon Debnath, PhD
Period of Support: 12/15/2022-12/14/2024
Total Direct Costs: $200,000
American Society for Bone and Mineral Research
Title: A multi-stem cell basis for craniosynostosis
Principal Investigator: Shawon Debnath, PhD
Period of Support: 01/01/2023-12/31/2023
Total Direct Costs: $15,000
National Institutes of Health (R01 grant)
Title: Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis
Principal Investigator: Nancy Du, PhD
Period of Support: 08/01/2022-07/31/2027
Total Direct Costs: $1,143,750
Charles A. Frueauff Foundation
Title: Equipment purchase for osteoporosis research
Principal Investigator: Matthew Greenblatt, MD PhD
Period of Support: 01/01/2023-12/31/2023
Total Direct Costs: $40,000
Pershing Square Foundation
Title: A bone to brain axis controlling Alzheimer’s disease progression
Principal Investigator: Matthew Greenblatt, MD PhD
Period of Support: 07/01/2023-06/30/2026
Total Direct Costs: $675,000
National Institutes of Health (R44 subaward)
Title: Quantitative mapping of dynamic epigenetic states in rare and stimulated immune cells
Principal Investigator: Steven Josefowicz, PhD
Period of Support: 08/18/2022-07/31/2023
Total Direct Costs: $123,894
National Institutes of Health (R01 supplement grant)
Title: Epigenetic alterations and phenotypes in innate immune cells and their progenitors in PASC
Principal Investigator: Steven Josefowicz, PhD
Period of Support: 08/08/2022-11/30/2024
Total Direct Costs: $177,089
STARR Cancer Consortium
Title: Mechanisms oof dynamic chromatin reorganization regulating B-cell differentiation and lymphomagenesis
Principal Investigator: Steven Josefowicz, PhD
Period of Support: 01/01/2023-12/31/2024
Total Direct Costs: $200,000
Burroughs Wellcome Fund
Title: Epigenetic regulation of immunity: molecular mechanisms of inflammatory priming and altered hematopoiesis
Principal Investigator: Steven Josefowicz, PhD
Period of Support: 07/01/2022-06/30/2027
Total Direct Costs: $500,000
National Institutes of Health (R35 grant)
Title: Destruction of noncoding RNAs
Principal Investigator: Benjamin Kleaveland, MD PhD
Period of Support: 07/01/2022-06/30/2027
Total Direct Costs: $1,250,000
Prostate Cancer Foundation
Title: Targeting lipid metabolism and diet in patients with locally advanced prostate cancer
Principal Investigator: Massimo Loda, MD
Period of Support: 12/23/2022-12/22/2024
Total Direct Costs: $1,000,000
National Institutes of Health (U54 subaward)
Title: Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center
Principal Investigator: Luigi Marchionni, MD PhD
Period of Support: 08/04/2022-07/31/2027
Total Direct Costs: $640,020
National Institutes of Health (R01 grant)
Title: Cholesterol metabolism in mesenchymal colorectal cancer
Principal Investigator: Jorge Moscat, PhD
Period of Support: 12/09/2022-11/30/2027
Total Direct Costs: $1,543,195
National Institutes of Health (R50 grant)
Title: Dissecting the in vivo stromal metabolic and inflammatory crosstalk in colorectal cancer
Principal Investigator: Maria Angeles Duran Molina, PhD/Jorge Moscat, PhD (Unit Director)
Period of Support: 8/16/2022-7/31/2027
Total Direct Costs: $524,435
Qatar National Research Foundation
Title: Differences in methylation profiles of prostate cancer (PCa) patients with different genetic ancestry
Principal Investigator: Juan Miguel Mosquera, MD
Period of Support: 11/01/2022-12/31/2022
Total Direct Costs: $300,000
National Institutes of Health (DP5 Diversity Supplement)
Title: Defining malignant hematopoiesis via single-cell multi-omics
Principal Investigator: Anna Nam, MD
Period of Support: 09/01/2022-08/30/2024
Total Direct Costs: $126,126
Scipio Bioscience
Title: Identifying signatures of metastatic disease using genetically engineered mouse models (GEMMS) of locally advanced and metastatic prostate cancer
Principal Investigator: Mohamed Omar PhD (Marchionni Lab)
Period of Support: 04/01/2023-03/31/24
Total Direct Costs: $30,000
National Institutes of Health (R01 supplement grant)
Title: Endothelial sphingolipid siignaling in post-sepsis cognitive impairment
Principal Investigator: Teresa Sanchez Garcia-Vao, PhD
Period of Support: 06/15/2022-05/31/2025
Total Direct Costs: $250,000
National Institutes of Health (R13 grant)
Title: 2nd Biennial ASBMB - BSC Symposium on the Interplay between Epigenetic Regulation and Genome Integrity
Principal Investigator: Jessica Tyler, PhD
Period of Support: 08/15/2022-07/31/2023
Total Direct Costs: $9,600
National Institutes of Health (R43 SBIR subaward)
Title: High-resolution genomic mapping of ssDNA and associated priteins for Alzheimer’s disease research
Principal Investigator: Jessica Tyler, PhD
Period of Support: 09/01/2022-06/30/2023
Total Direct Costs: $88,496
National Institutes of Health (R01 subaward)
Title: Development of Targeted Antipseudomonal Bactericidal Prodrugs
Principal Investigator: Lars Westblade, PhD
Period of Support: 04/01/2023-03/31/2028
Total Direct Costs: $200,000
National Institutes of Health (R01 grant)
Title: UBR5's mechanisms of action in tumorigenesis and immunoregulation
Principal Investigator: Pengbo Zhou, PhD (Co-PI Xiaojing Ma)
Period of Support: 03/01/2023-02/28/2028
Total Direct Costs: $611,590
Weill Cornell Medicine Internal Grants
Cornell China Center
Title: A stem cell basis for vertebral metastases
Principal Investigator: Matthew Greenblatt, MD PhD
Period of Support: 07/01/2023-06/30/2024
Total Direct Costs: $15,000
Weill Cornell Medicine Dean’s Office (Jumpstart award)
Title: A Tri-stem cell basis for calvarial mineralization and neuroinflammatiion
Principal Investigator: Seoyeon Bok, PhD
Period of Support: 07/01/2022-06/30/2025
Total Direct Costs: $300,000
Meyer Cancer Center Collaborative Research Initiative
Title: Characterization of Alternative polyadenylation as a determinant of tumor progression and immunotherapy response
Principal Investigator: Luigi Marchionni, MD PhD
Period of Support: 07/01/2022-06/30/2023
Total Direct Costs: $50,000
Cornell Center for Pandemic Prevention and Response
Title: Clinical utility of viral load quantification in influenza infections
Principal Investigator: Lars Westblade, PhD
Period of Support: 12/01/2022-11/30/2023
Total Direct Costs: $75,000
WCM Clinical & Translational Science Center
Title: Effects of In-Utero SARS-Cov-2 exposure and immunity on pediatric outcomes
Principal Investigator: Yawei (Jenny) Yang, MD PhD
Period of Support: 07/01/2022-06/30/2023
Total Direct Costs: $50,000
WCM Clinical & Translational Science Center
Title: WCM Clinical and Translational Science Center (CTSC)
Principal Investigator: Pengbo Zhou, PhD
Period of Support: 07/01/2022-06/30/2023
Total Direct Costs: $50,000
National Institutes of Health/WCM (SPORE DRP Pilot grant)
Title: Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
Principal Investigator: Massimo Loda, MD; PI Pilot Award: Pengbo Zhou, PhD
Period of Support: 10/01/2022-09/30/2023
Total Direct Costs: $75,000
Industry Sponsored Research Agreements
Selux Diagnostics
Title: Performance comparison of rapid Antimicrobial Susceptibility Test (AST) system for clinical isolate colonies
Principal Investigator: Lars Westblade, PhD
Period of Support: 08/01/2022-07/31/2023
Total Direct Costs: $28,203
Vividion Therapeutics
Title: Sponsored Research Agreement
Principal Investigator: Giorgio Inghirami, MD
Period of Support: 01/01/2023-12/31/2023
Total Direct Costs: $32,253
Chimerix, Inc.
Title: Development of Next-Generation Therapeutics for Advanced Prostate Cancer
Principal Investigator: David Rickman, PhD
Period of Support: 09/30/2022-09/29/2023
Total Direct Costs: $100,125
Fellowships
National Institutes of Health (UM1 Fellowship)
Title: The AIDS Malignancy Consortium Grant (AMC)
Principal Investigator: Sanjay Patel, MD
Period of Support: 09/01/2022- 08/31/2023
Total Direct Costs: $25,000
National Institutes of Health (UM1 Fellowship)
Title: The AIDS Malignancy Consortium Grant (AMC)
Principal Investigator: Paul Simonson, MD, PhD
Period of Support: 09/01/2022- 08/31/2023
Total Direct Costs: $25,000